BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (BGLC) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
bglc · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, BioNexus Gene Lab Corp. (BGLC) has a market cap — also referred to as its net worth or valuation — of $4,405,448, making it one of the top most valuable companies globally. Market Cap = $2.19 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
BioNexus Gene Lab Corp. (BGLC) has a market cap — also referred to as its net worth or valuation — of $4,405,448 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
BioNexus Gene Lab Corp. reached its all-time high market cap of $896,475,471.324 on Jan 19, 2022. Comparing the BioNexus Gene Lab Corp. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare BioNexus Gene Lab Corp. net worth vs peers and ask how BioNexus Gene Lab Corp. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
BGLC market cap · 6 questionsBioNexus Gene Lab Corp.'s net worth — measured as market capitalization — is $4,405,448 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$2.19 (price) × shares outstanding.